Table 2.
Results from Generalized Linear Modeling Comparing Total Cholesterol Levels Between APOE Genotypes.
| Variable | LSM (SE) (mg/dL) | Estimate | 95% CI | χ2 | p-value |
|---|---|---|---|---|---|
|
| |||||
| APOE Genotype | |||||
| APOE2+ | 187.40 (3.47) | −7.48 | −14.65, −0.31 | 4.18 | < 0.05 |
| APOE3 | 188.88 (1.49) | −6.00 | −9.80, −2.20 | 9.58 | < 0.01 |
| APOE4+ | 194.88 (1.42) | 0.00 | |||
| CM Use | −19.94 | −24.10, −15.78 | 88.31 | < 0.0001 | |
| Sex (F) | 27.14 | 23.47, 30.81 | 210.20 | < 0.0001 | |
| Age | −0.44 | −0.69, −0.18 | 11.36 | < 0.001 | |
LSM, least square mean of total cholesterol; SE, standard error; CI, confidence interval; CM, cholesterol-lowering medication.